Delivery Order SPE2DB24D8003-SPE2DB25FJTTG
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,280.00 fixed-price contract is for the delivery of 4 mg Ondansetron orally disintegrating tablets in 30-count packages. The contract is not set aside and has a performance period through February 12, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,928.10, is for the delivery of 4563372594 - Ondansetron ODT 4 mg tablets. The contract has a period of performance through January 22, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a prescription medication, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,649.98 and a performance period that runs through November 22, 2024. This Delivery Order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,481.81, is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price arrangement with a completion date of May 9, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $5,643.33, is for the delivery of Ondansetron ODT 4 mg tablets. It is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $3,331.66, is for the delivery of ondansetron odt 4 mg tablets in a 30-count package. The contract has a firm fixed price pricing type and a completion date of June 4, 2024. Dakota Drug, Inc. is a critical supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Ondansetron ODT 4 mg tablets. The $3,095.46 firm fixed-price contract has a performance period extending to February 7, 2025. This award is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00. This IDC allows Dakota...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,958.24, is a firm-fixed-price delivery order for 4,567,087,425 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment...
This delivery order contract, valued at $1,993.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of 4,563,982 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with a performance period through March 18, 2024. This award is made as a firm fixed-price delivery order without any set-aside designation. Dakota Drug, Inc. has a long-standing history as a...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYXK, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,759.71, is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products,...